Literature DB >> 22897149

Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation.

Bengt von Zur-Mühlen, Gunnar Tufveson, Olle Korsgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22897149      PMCID： PMC3439568          DOI： 10.1111/j.1432-2277.2012.01545.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  11 in total

1.  Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants.

Authors:  Paolo Fiorina; Franco Folli; Gianpaolo Zerbini; Paola Maffi; Chiara Gremizzi; Valerio Di Carlo; Carlo Socci; Federico Bertuzzi; Michael Kashgarian; Antonio Secchi
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

2.  Chemical immunosuppression in islet transplantation--friend or foe?

Authors:  Lucienne Chatenoud
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF.

Authors:  Tatiana Froud; David A Baidal; Gaston Ponte; Jacqueline V Ferreira; Camillo Ricordi; Rodolfo Alejandro
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

4.  Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy.

Authors:  David M Thompson; Mark Meloche; Ziliang Ao; Breay Paty; Paul Keown; R Jean Shapiro; Stephen Ho; Dan Worsley; Michelle Fung; Graydon Meneilly; Iain Begg; Mohammed Al Mehthel; Joma Kondi; Claire Harris; Blake Fensom; Sharon E Kozak; Suet On Tong; Mary Trinh; Garth L Warnock
Journal:  Transplantation       Date:  2011-02-15       Impact factor: 4.939

5.  Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.

Authors:  L A Øzbay; K Smidt; D M Mortensen; J Carstens; K A Jørgensen; J Rungby
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

7.  New-onset diabetes after renal transplantation.

Authors:  Pablo F Mora
Journal:  J Investig Med       Date:  2010-08       Impact factor: 2.895

8.  Diabetes mellitus after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David Gilbertson; Arthur J Matas
Journal:  Am J Transplant       Date:  2003-02       Impact factor: 8.086

9.  Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.

Authors:  James D Johnson; Ziliang Ao; Peter Ao; Hong Li; Long-Jun Dai; Zehua He; May Tee; Kathryn J Potter; Agnieszka M Klimek; R Mark Meloche; David M Thompson; C Bruce Verchere; Garth L Warnock
Journal:  Cell Transplant       Date:  2009-04-10       Impact factor: 4.064

10.  Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.

Authors:  P Troncoso; A M Ortiz; A Jara; S Vilches
Journal:  Transplant Proc       Date:  2009 Jan-Feb       Impact factor: 1.066
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.